TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs12140275
log Bayes Factor = 1.29665
Chromosome 1   position 38,633,879  (GRCh37) Explore rs12140275 on Ensembl!
Variant rs12140275 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C56 Malignant neoplasm of ovary
0.000 0.140 0.860
C51-C58 Malignant neoplasms of female genital organs
0.000 0.169 0.831
C53 Malignant neoplasm of cervix uteri
0.000 0.177 0.823
C53.9 Cervix uteri, unspecified
0.000 0.182 0.818
C57 Malignant neoplasm of other and unspecified female genital organs
0.000 0.247 0.753
C55 Malignant neoplasm of uterus, part unspecified
0.000 0.270 0.730
C57.0 Fallopian tube
0.000 0.308 0.692
C58 Malignant neoplasm of placenta
0.000 0.404 0.596
C53.0 Endocervix
0.000 0.407 0.593
C53.8 Overlapping lesion of cervix uteri
0.000 0.410 0.590
C53.1 Exocervix
0.000 0.410 0.590
E03.9 Hypothyroidism, unspecified
0.000 0.434 0.566
C57.9 Female genital organ, unspecified
0.000 0.443 0.557
E03 Other hypothyroidism
0.000 0.458 0.542
C52 Malignant neoplasm of vagina
0.000 0.459 0.541
C57.8 Overlapping lesion of female genital organs
0.000 0.460 0.540
C57.7 Other specified female genital organs
0.000 0.460 0.540
C57.4 Uterine adnexa, unspecified
0.000 0.460 0.540
C57.3 Parametrium
0.000 0.460 0.540
C57.2 Round ligament
0.000 0.460 0.540
C57.1 Broad ligament
0.000 0.460 0.540
E00-E07 Disorders of thyroid gland
0.000 0.470 0.530
E04 Other non-toxic goitre
0.000 0.496 0.504
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.511 0.489
E20-E35 Disorders of other endocrine glands
0.000 0.512 0.488
E27 Other disorders of adrenal gland
0.000 0.527 0.473
E27.8 Other specified disorders of adrenal gland
0.000 0.554 0.446
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.558 0.441
C51 Malignant neoplasm of vulva
0.000 0.559 0.440
E04.2 Non-toxic multinodular goitre
0.000 0.560 0.440
E04.0 Non-toxic diffuse goitre
0.000 0.567 0.433
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.574 0.426
E20 Hypoparathyroidism
0.000 0.579 0.421
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.579 0.421
E16 Other disorders of pancreatic internal secretion
0.000 0.592 0.408
E50-E64 Other nutritional deficiencies
0.000 0.595 0.405
E34 Other endocrine disorders
0.000 0.598 0.402
E03.8 Other specified hypothyroidism
0.000 0.598 0.402
E04.9 Non-toxic goitre, unspecified
0.000 0.598 0.402
E23 Hypofunction and other disorders of pituitary gland
0.000 0.601 0.399
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.607 0.393
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.607 0.392
E04.1 Non-toxic single thyroid nodule
0.000 0.609 0.391
E03.5 Myxoedema coma
0.000 0.611 0.388
E03.4 Atrophy of thyroid (acquired)
0.000 0.611 0.388
E03.3 Postinfectious hypothyroidism
0.000 0.611 0.388
E03.1 Congenital hypothyroidism without goitre
0.000 0.611 0.388
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.611 0.388
E16.2 Hypoglycaemia, unspecified
0.000 0.614 0.386
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.620 0.380
E00 Congenital iodine-deficiency syndrome
0.000 0.620 0.380
E20.9 Hypoparathyroidism, unspecified
0.000 0.627 0.373
E27.9 Disorder of adrenal gland, unspecified
0.000 0.631 0.369
E40-E46 Malnutrition
0.000 0.633 0.366
E04.8 Other specified non-toxic goitre
0.000 0.638 0.362
E28 Ovarian dysfunction
0.000 0.640 0.360
E26 Hyperaldosteronism
0.000 0.642 0.358
E05.9 Thyrotoxicosis, unspecified
0.000 0.642 0.358
E22 Hyperfunction of pituitary gland
0.000 0.642 0.358
E61 Deficiency of other nutrient elements
0.000 0.644 0.356
E25 Adrenogenital disorders
0.000 0.647 0.353
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.650 0.350
E32 Diseases of thymus
0.000 0.650 0.350
E30 Disorders of puberty, not elsewhere classified
0.000 0.650 0.350
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.651 0.349
E24 Cushing's syndrome
0.000 0.658 0.342
E27.5 Adrenomedullary hyperfunction
0.000 0.661 0.339
E27.0 Other adrenocortical overactivity
0.000 0.661 0.339
E23.0 Hypopituitarism
0.000 0.663 0.337
E34.8 Other specified endocrine disorders
0.000 0.663 0.337
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.667 0.333
E31 Polyglandular dysfunction
0.000 0.669 0.331
E07 Other disorders of thyroid
0.000 0.672 0.328
E65-E68 Obesity and other hyperalimentation
0.000 0.672 0.328
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.677 0.323
E61.1 Iron deficiency
0.000 0.681 0.319
E28.3 Primary ovarian failure
0.000 0.681 0.319
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.683 0.317
E15 Nondiabetic hypoglycaemic coma
0.000 0.683 0.317
E27.1 Primary adrenocortical insufficiency
0.000 0.683 0.316
C51.8 Overlapping lesion of vulva
0.000 0.684 0.316
C51.2 Clitoris
0.000 0.684 0.316
C51.1 Labium minus
0.000 0.684 0.316
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.686 0.313
E55 Vitamin D deficiency
0.000 0.687 0.313
E23.7 Disorder of pituitary gland, unspecified
0.000 0.688 0.312
C54 Malignant neoplasm of corpus uteri
0.000 0.690 0.310
E06 Thyroiditis
0.000 0.692 0.308
C51.0 Labium majus
0.000 0.694 0.306
E27.2 Addisonian crisis
0.000 0.697 0.303
E20.8 Other hypoparathyroidism
0.000 0.698 0.302
E20.1 Pseudohypoparathyroidism
0.000 0.698 0.302
E20.0 Idiopathic hypoparathyroidism
0.000 0.698 0.302
E29 Testicular dysfunction
0.000 0.698 0.302
E34.0 Carcinoid syndrome
0.000 0.703 0.297
E21.0 Primary hyperparathyroidism
0.000 0.705 0.295
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.707 0.293
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.707 0.293
E16.4 Abnormal secretion of gastrin
0.000 0.707 0.293
E16.3 Increased secretion of glucagon
0.000 0.707 0.293
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.709 0.291
E63 Other nutritional deficiencies
0.000 0.709 0.291
E50 Vitamin A deficiency
0.000 0.709 0.291
E60 Dietary zinc deficiency
0.000 0.709 0.291
E59 Dietary selenium deficiency
0.000 0.709 0.291
E54 Ascorbic acid deficiency
0.000 0.709 0.291
E52 Niacin deficiency [pellagra]
0.000 0.709 0.291
E16.1 Other hypoglycaemia
0.000 0.711 0.289
E34.5 Androgen resistance syndrome
0.000 0.711 0.288
E34.4 Constitutional tall stature
0.000 0.711 0.288
E34.3 Short stature, not elsewhere classified
0.000 0.711 0.288
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.711 0.288
E34.1 Other hypersecretion of intestinal hormones
0.000 0.711 0.288
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.712 0.288
E34.9 Endocrine disorder, unspecified
0.000 0.714 0.286
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.714 0.286
E23.1 Drug-induced hypopituitarism
0.000 0.714 0.286
E53 Deficiency of other B group vitamins
0.000 0.714 0.286
E58 Dietary calcium deficiency
0.000 0.717 0.283
E23.6 Other disorders of pituitary gland
0.000 0.717 0.283
E21.4 Other specified disorders of parathyroid gland
0.000 0.718 0.282
E21.2 Other hyperparathyroidism
0.000 0.718 0.282
E05.5 Thyroid crisis or storm
0.000 0.718 0.281
E05.4 Thyrotoxicosis factitia
0.000 0.718 0.281
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.718 0.281
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.718 0.281
E46 Unspecified protein-energy malnutrition
0.000 0.721 0.279
E21.3 Hyperparathyroidism, unspecified
0.000 0.724 0.276
E51 Thiamine deficiency
0.000 0.726 0.274
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.727 0.273
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.727 0.273
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.727 0.273
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.727 0.273
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.727 0.273
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.727 0.273
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.727 0.273
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.727 0.273
E56 Other vitamin deficiencies
0.000 0.730 0.270
E26.0 Primary hyperaldosteronism
0.000 0.735 0.265
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.737 0.263
E45 Retarded development following protein-energy malnutrition
0.000 0.737 0.263
E43 Unspecified severe protein-energy malnutrition
0.000 0.737 0.263
E42 Marasmic kwashiorkor
0.000 0.737 0.263
E41 Nutritional marasmus
0.000 0.737 0.263
E40 Kwashiorkor
0.000 0.737 0.263
E65 Localised adiposity
0.000 0.737 0.263
E61.2 Magnesium deficiency
0.000 0.741 0.259
E24.2 Drug-induced Cushing's syndrome
0.000 0.741 0.259
E28.9 Ovarian dysfunction, unspecified
0.000 0.742 0.258
E28.8 Other ovarian dysfunction
0.000 0.742 0.258
E28.1 Androgen excess
0.000 0.742 0.258
E28.0 Oestrogen excess
0.000 0.742 0.258
E26.9 Hyperaldosteronism, unspecified
0.000 0.743 0.257
E26.8 Other hyperaldosteronism
0.000 0.743 0.257
E26.1 Secondary hyperaldosteronism
0.000 0.743 0.257
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.743 0.257
E22.8 Other hyperfunction of pituitary gland
0.000 0.743 0.257
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.744 0.255
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.745 0.255
E61.9 Deficiency of nutrient element, unspecified
0.000 0.745 0.255
E61.8 Deficiency of other specified nutrient elements
0.000 0.745 0.255
E61.7 Deficiency of multiple nutrient elements
0.000 0.745 0.255
E61.6 Vanadium deficiency
0.000 0.745 0.255
E61.5 Molybdenum deficiency
0.000 0.745 0.255
E61.4 Chromium deficiency
0.000 0.745 0.255
E61.3 Manganese deficiency
0.000 0.745 0.255
E61.0 Copper deficiency
0.000 0.745 0.255
E25.9 Adrenogenital disorder, unspecified
0.000 0.747 0.253
E25.8 Other adrenogenital disorders
0.000 0.747 0.253
E30.9 Disorder of puberty, unspecified
0.000 0.749 0.251
E30.8 Other disorders of puberty
0.000 0.749 0.251
E30.1 Precocious puberty
0.000 0.749 0.251
E30.0 Delayed puberty
0.000 0.749 0.251
E32.9 Disease of thymus, unspecified
0.000 0.749 0.251
E32.8 Other diseases of thymus
0.000 0.749 0.251
E32.1 Abscess of thymus
0.000 0.749 0.251
E32.0 Persistent hyperplasia of thymus
0.000 0.749 0.251
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.749 0.251
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.749 0.251
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.749 0.251
E23.2 Diabetes insipidus
0.000 0.749 0.251
E05.8 Other thyrotoxicosis
0.000 0.751 0.249
E24.9 Cushing's syndrome, unspecified
0.000 0.752 0.248
E55.9 Vitamin D deficiency, unspecified
0.000 0.753 0.247
E24.8 Other Cushing's syndrome
0.000 0.754 0.245
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.754 0.245
E24.3 Ectopic ACTH syndrome
0.000 0.754 0.245
E24.1 Nelson's syndrome
0.000 0.754 0.245
E07.9 Disorder of thyroid, unspecified
0.000 0.755 0.245
E31.9 Polyglandular dysfunction, unspecified
0.000 0.762 0.237
E31.8 Other polyglandular dysfunction
0.000 0.762 0.237
E31.1 Polyglandular hyperfunction
0.000 0.762 0.237
E07.1 Dyshormogenetic goitre
0.000 0.764 0.235
E07.0 Hypersecretion of calcitonin
0.000 0.764 0.235
E67 Other hyperalimentation
0.000 0.765 0.235
E68 Sequelae of hyperalimentation
0.000 0.765 0.235
E53.9 Vitamin B deficiency, unspecified
0.000 0.772 0.228
E55.0 Rickets, active
0.000 0.775 0.225
C54.8 Overlapping lesion of corpus uteri
0.000 0.777 0.222
C54.3 Fundus uteri
0.000 0.777 0.222
C54.2 Myometrium
0.000 0.777 0.222
C54.0 Isthmus uteri
0.000 0.777 0.222
E06.4 Drug-induced thyroiditis
0.000 0.779 0.221
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.779 0.221
E06.1 Subacute thyroiditis
0.000 0.779 0.221
E06.0 Acute thyroiditis
0.000 0.779 0.221
E31.0 Autoimmune polyglandular failure
0.000 0.781 0.218
E24.0 Pituitary-dependent Cushing's disease
0.000 0.782 0.218
E29.9 Testicular dysfunction, unspecified
0.000 0.783 0.217
E29.8 Other testicular dysfunction
0.000 0.783 0.217
E29.0 Testicular hyperfunction
0.000 0.783 0.217
E06.3 Autoimmune thyroiditis
0.000 0.785 0.215
E06.5 Other chronic thyroiditis
0.000 0.789 0.211
E22.0 Acromegaly and pituitary gigantism
0.000 0.790 0.210
E50.9 Vitamin A deficiency, unspecified
0.000 0.791 0.208
E50.8 Other manifestations of vitamin A deficiency
0.000 0.791 0.208
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.791 0.208
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.791 0.208
E50.5 Vitamin A deficiency with night blindness
0.000 0.791 0.208
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.791 0.208
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.791 0.208
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.791 0.208
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.791 0.208
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.791 0.208
E63.9 Nutritional deficiency, unspecified
0.000 0.791 0.208
E63.8 Other specified nutritional deficiencies
0.000 0.791 0.208
E63.1 Imbalance of constituents of food intake
0.000 0.791 0.208
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.791 0.208
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.791 0.208
E64.8 Sequelae of other nutritional deficiencies
0.000 0.791 0.208
E64.3 Sequelae of rickets
0.000 0.791 0.208
E64.2 Sequelae of vitamin C deficiency
0.000 0.791 0.208
E64.1 Sequelae of vitamin A deficiency
0.000 0.791 0.208
E64.0 Sequelae of protein-energy malnutrition
0.000 0.791 0.208
E53.1 Pyridoxine deficiency
0.000 0.795 0.205
E53.0 Riboflavin deficiency
0.000 0.795 0.205
E51.9 Thiamine deficiency, unspecified
0.000 0.803 0.196
E51.8 Other manifestations of thiamine deficiency
0.000 0.803 0.196
E51.1 Beriberi
0.000 0.803 0.196
E56.9 Vitamin deficiency, unspecified
0.000 0.806 0.194
E56.8 Deficiency of other vitamins
0.000 0.806 0.194
E56.0 Deficiency of vitamin E
0.000 0.806 0.194
E44.1 Mild protein-energy malnutrition
0.000 0.811 0.189
E44.0 Moderate protein-energy malnutrition
0.000 0.811 0.189
C51.9 Vulva, unspecified
0.001 0.819 0.181
C54.9 Corpus uteri, unspecified
0.000 0.820 0.180
E51.2 Wernicke's encephalopathy
0.000 0.820 0.180
E06.9 Thyroiditis, unspecified
0.000 0.825 0.175
E22.1 Hyperprolactinaemia
0.000 0.827 0.173
E56.1 Deficiency of vitamin K
0.000 0.827 0.173
E67.8 Other specified hyperalimentation
0.000 0.831 0.169
E67.3 Hypervitaminosis D
0.000 0.831 0.169
E67.2 Megavitamin-B6 syndrome
0.000 0.831 0.169
E67.1 Hypercarotenaemia
0.000 0.831 0.169
E67.0 Hypervitaminosis A
0.000 0.831 0.169
E29.1 Testicular hypofunction
0.000 0.831 0.169
E07.8 Other specified disorders of thyroid
0.000 0.832 0.167
E53.8 Deficiency of other specified B group vitamins
0.000 0.835 0.165
E66 Obesity
0.000 0.837 0.163
E28.2 Polycystic ovarian syndrome
0.000 0.867 0.133
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.876 0.124
E66.0 Obesity due to excess calories
0.000 0.877 0.123
I47.2 Ventricular tachycardia
0.000 0.880 0.120
E66.1 Drug-induced obesity
0.000 0.883 0.117
E66.8 Other obesity
0.000 0.897 0.103
M06.9 Rheumatoid arthritis, unspecified
0.000 0.909 0.091
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.909 0.091
E10-E14 Diabetes mellitus
0.000 0.914 0.086
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.916 0.084
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.919 0.081
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.922 0.077
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.927 0.073
M06 Other rheumatoid arthritis
0.000 0.929 0.071
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.933 0.067
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.933 0.067
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.935 0.064
M06.3 Rheumatoid nodule
0.000 0.937 0.063
E12 Malnutrition-related diabetes mellitus
0.000 0.938 0.062
M06.4 Inflammatory polyarthropathy
0.000 0.938 0.062
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.941 0.059
C54.1 Endometrium
0.000 0.942 0.058
M06.49 Inflammatory polyarthropathy (Site unspecified)
0.000 0.944 0.056
M06.37 Rheumatoid nodule (Ankle and foot)
0.000 0.944 0.056
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.944 0.055
M06.32 Rheumatoid nodule (Upper arm)
0.000 0.948 0.052
M06.2 Rheumatoid bursitis
0.000 0.949 0.051
M06.1 Adult-onset Still's disease
0.000 0.949 0.051
M06.0 Seronegative rheumatoid arthritis
0.000 0.950 0.050
E11 Non-insulin-dependent diabetes mellitus
0.000 0.950 0.050
M06.8 Other specified rheumatoid arthritis
0.000 0.951 0.049
E11.4 With neurological complications
0.000 0.953 0.047
E13 Other specified diabetes mellitus
0.000 0.954 0.046
M06.39 Rheumatoid nodule (Site unspecified)
0.000 0.955 0.045
M06.38 Rheumatoid nodule (Other)
0.000 0.955 0.045
M06.36 Rheumatoid nodule (Lower leg)
0.000 0.955 0.045
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.000 0.955 0.045
M06.33 Rheumatoid nodule (Forearm)
0.000 0.955 0.045
M06.31 Rheumatoid nodule (Shoulder region)
0.000 0.955 0.045
E12.9 Without complications
0.000 0.955 0.045
E12.8 With unspecified complications
0.000 0.955 0.045
E12.7 With multiple complications
0.000 0.955 0.045
E12.6 With other specified complications
0.000 0.955 0.045
E12.5 With peripheral circulatory complications
0.000 0.955 0.045
E12.4 With neurological complications
0.000 0.955 0.045
E12.3 With ophthalmic complications
0.000 0.955 0.045
E12.2 With renal complications
0.000 0.955 0.045
E12.1 With ketoacidosis
0.000 0.955 0.045
E12.0 With coma
0.000 0.955 0.045
M06.48 Inflammatory polyarthropathy (Other)
0.000 0.955 0.044
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.000 0.955 0.044
M06.46 Inflammatory polyarthropathy (Lower leg)
0.000 0.955 0.044
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.000 0.955 0.044
M06.44 Inflammatory polyarthropathy (Hand)
0.000 0.955 0.044
M06.43 Inflammatory polyarthropathy (Forearm)
0.000 0.955 0.044
M06.42 Inflammatory polyarthropathy (Upper arm)
0.000 0.955 0.044
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.000 0.955 0.044
R19.0 Intra-abdominal and pelvic swelling, mass and lump
0.000 0.956 0.044
M06.34 Rheumatoid nodule (Hand)
0.000 0.956 0.044
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.000 0.958 0.042
E11.2 With renal complications
0.000 0.959 0.041
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.000 0.959 0.041
E14 Unspecified diabetes mellitus
0.000 0.960 0.040
M06.30 Rheumatoid nodule (Multiple sites)
0.000 0.961 0.039
E11.0 With coma
0.000 0.961 0.039
E11.6 With other specified complications
0.000 0.961 0.038
E66.9 Obesity, unspecified
0.000 0.962 0.038
M06.19 Adult-onset Still's disease (Site unspecified)
0.000 0.963 0.037
M06.18 Adult-onset Still's disease (Other)
0.000 0.963 0.037
M06.17 Adult-onset Still's disease (Ankle and foot)
0.000 0.963 0.037
M06.16 Adult-onset Still's disease (Lower leg)
0.000 0.963 0.037
M06.15 Adult-onset Still's disease (Pelvic region and thigh)
0.000 0.963 0.037
M06.14 Adult-onset Still's disease (Hand)
0.000 0.963 0.037
M06.13 Adult-onset Still's disease (Forearm)
0.000 0.963 0.037
M06.12 Adult-onset Still's disease (Upper arm)
0.000 0.963 0.037
M06.11 Adult-onset Still's disease (Shoulder region)
0.000 0.963 0.037
M06.10 Adult-onset Still's disease (Multiple sites)
0.000 0.963 0.037
M06.29 Rheumatoid bursitis (Site unspecified)
0.000 0.963 0.037
M06.28 Rheumatoid bursitis (Other)
0.000 0.963 0.037
M06.27 Rheumatoid bursitis (Ankle and foot)
0.000 0.963 0.037
M06.26 Rheumatoid bursitis (Lower leg)
0.000 0.963 0.037
M06.25 Rheumatoid bursitis (Pelvic region and thigh)
0.000 0.963 0.037
M06.24 Rheumatoid bursitis (Hand)
0.000 0.963 0.037
M06.23 Rheumatoid bursitis (Forearm)
0.000 0.963 0.037
M06.22 Rheumatoid bursitis (Upper arm)
0.000 0.963 0.037
M06.21 Rheumatoid bursitis (Shoulder region)
0.000 0.963 0.037
M06.20 Rheumatoid bursitis (Multiple sites)
0.000 0.963 0.037
M06.08 Seronegative rheumatoid arthritis (Other)
0.000 0.964 0.036
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)
0.000 0.964 0.036
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)
0.000 0.964 0.036
M06.04 Seronegative rheumatoid arthritis (Hand)
0.000 0.964 0.036
M06.03 Seronegative rheumatoid arthritis (Forearm)
0.000 0.964 0.036
M06.02 Seronegative rheumatoid arthritis (Upper arm)
0.000 0.964 0.036
M06.01 Seronegative rheumatoid arthritis (Shoulder region)
0.000 0.964 0.036
E11.7 With multiple complications
0.000 0.964 0.036
M06.88 Other specified rheumatoid arthritis (Other)
0.000 0.965 0.035
M06.87 Other specified rheumatoid arthritis (Ankle and foot)
0.000 0.965 0.035
M06.86 Other specified rheumatoid arthritis (Lower leg)
0.000 0.965 0.035
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)
0.000 0.965 0.035
M06.84 Other specified rheumatoid arthritis (Hand)
0.000 0.965 0.035
M06.83 Other specified rheumatoid arthritis (Forearm)
0.000 0.965 0.035
M06.82 Other specified rheumatoid arthritis (Upper arm)
0.000 0.965 0.035
M06.81 Other specified rheumatoid arthritis (Shoulder region)
0.000 0.965 0.035
M06.80 Other specified rheumatoid arthritis (Multiple sites)
0.000 0.965 0.035
M06.06 Seronegative rheumatoid arthritis (Lower leg)
0.000 0.965 0.035
E11.3 With ophthalmic complications
0.000 0.965 0.035
E13.8 With unspecified complications
0.000 0.967 0.033
E13.7 With multiple complications
0.000 0.967 0.033
E13.6 With other specified complications
0.000 0.967 0.033
E13.5 With peripheral circulatory complications
0.000 0.967 0.033
E13.4 With neurological complications
0.000 0.967 0.033
E13.3 With ophthalmic complications
0.000 0.967 0.033
E13.2 With renal complications
0.000 0.967 0.033
E13.1 With ketoacidosis
0.000 0.967 0.033
E13.0 With coma
0.000 0.967 0.033
M06.89 Other specified rheumatoid arthritis (Site unspecified)
0.000 0.967 0.033
E11.5 With peripheral circulatory complications
0.000 0.968 0.032
E05.0 Thyrotoxicosis with diffuse goitre
0.002 0.968 0.030
E14.5 With peripheral circulatory complications
0.000 0.969 0.031
E14.8 With unspecified complications
0.000 0.970 0.030
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.000 0.971 0.029
E14.7 With multiple complications
0.000 0.971 0.029
E14.0 With coma
0.000 0.971 0.029
E14.4 With neurological complications
0.000 0.971 0.029
D05.9 Carcinoma in situ of breast, unspecified
0.028 0.972 0.000
E14.6 With other specified complications
0.000 0.972 0.028
E14.1 With ketoacidosis
0.000 0.972 0.028
E11.1 With ketoacidosis
0.000 0.973 0.027
E11.8 With unspecified complications
0.000 0.975 0.025
E10 Insulin-dependent diabetes mellitus
0.000 0.975 0.025
E14.3 With ophthalmic complications
0.000 0.975 0.025
E14.2 Withrenal complications
0.000 0.976 0.024
I47 Paroxysmal tachycardia
0.000 0.976 0.024
C16.0 Cardia
0.022 0.978 0.000
E10.6 With other specified complications
0.000 0.979 0.021
E10.8 With unspecified complications
0.000 0.979 0.021
I47.9 Paroxysmal tachycardia, unspecified
0.000 0.980 0.020
E14.9 Without complications
0.000 0.981 0.019
E10.3 With ophthalmic complications
0.000 0.982 0.018
C16 Malignant neoplasm of stomach
0.018 0.982 0.000
C16.5 Lesser curvature of stomach, unspecified
0.017 0.983 0.000
E13.9 Without complications
0.000 0.983 0.016
E10.7 With multiple complications
0.000 0.984 0.016
E10.0 With coma
0.000 0.984 0.016
E10.4 With neurological complications
0.000 0.984 0.016
E10.2 With renal complications
0.000 0.984 0.016
C16.6 Greater curvature of stomach, unspecified
0.014 0.986 0.000
C16.1 Fundus of stomach
0.014 0.986 0.000
C16.9 Stomach, unspecified
0.014 0.986 0.000
E70-E90 Metabolic disorders
0.000 0.986 0.014
E10.5 With peripheral circulatory complications
0.000 0.987 0.013
C16.8 Overlapping lesion of stomach
0.013 0.987 0.000
C16.4 Pylorus
0.013 0.987 0.000
E10.1 With ketoacidosis
0.000 0.987 0.013
C16.3 Pyloric antrum
0.012 0.987 0.000
E88 Other metabolic disorders
0.000 0.988 0.012
E85 Amyloidosis
0.000 0.988 0.012
I47.0 Reentry ventricular arrhythmia
0.000 0.988 0.012
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.988 0.012
O80.0 Spontaneous vertex delivery
0.012 0.988 0.000
C16.2 Body of stomach
0.012 0.988 0.000
I46.9 Cardiac arrest, unspecified
0.000 0.988 0.012
E10.9 Without complications
0.000 0.989 0.011
E85.9 Amyloidosis, unspecified
0.000 0.989 0.011
E73 Lactose intolerance
0.000 0.989 0.011
E88.8 Other specified metabolic disorders
0.000 0.990 0.010
E85.3 Secondary systemic amyloidosis
0.000 0.990 0.010
E77 Disorders of glycoprotein metabolism
0.000 0.990 0.010
E76 Disorders of glycosaminoglycan metabolism
0.000 0.990 0.010
E72 Other disorders of amino-acid metabolism
0.000 0.990 0.010
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.990 0.010
E70 Disorders of aromatic amino-acid metabolism
0.000 0.990 0.010
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.990 0.010
M05-M14 Inflammatory polyarthropathies
0.000 0.990 0.010
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.990 0.010
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.990 0.009
M13.09 Polyarthritis, unspecified (Site unspecified)
0.000 0.991 0.009
E84 Cystic fibrosis
0.000 0.991 0.009
E85.4 Organ-limited amyloidosis
0.000 0.991 0.009
E79 Disorders of purine and pyrimidine metabolism
0.000 0.991 0.009
E88.3 Tumour lysis syndrome
0.000 0.991 0.009
E85.8 Other amyloidosis
0.000 0.991 0.009
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.991 0.009
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.991 0.009
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.991 0.009
Z83.5 Family history of eye and ear disorders
0.009 0.991 0.000
K86.1 Other chronic pancreatitis
0.000 0.991 0.009
M13.0 Polyarthritis, unspecified
0.000 0.991 0.009
D05 Carcinoma in situ of breast
0.008 0.992 0.000
E73.9 Lactose intolerance, unspecified
0.000 0.992 0.008
E88.9 Metabolic disorder, unspecified
0.000 0.992 0.008
E74 Other disorders of carbohydrate metabolism
0.000 0.992 0.008
M13 Other arthritis
0.000 0.992 0.008
E73.8 Other lactose intolerance
0.000 0.992 0.008
E73.1 Secondary lactase deficiency
0.000 0.992 0.008
E73.0 Congenital lactase deficiency
0.000 0.992 0.008
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.992 0.008
D46.9 Myelodysplastic syndrome, unspecified
0.000 0.992 0.008
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.993 0.007
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.993 0.007
E70.3 Albinism
0.000 0.993 0.007
E70.2 Disorders of tyrosine metabolism
0.000 0.993 0.007
E70.1 Other hyperphenylalaninaemias
0.000 0.993 0.007
E70.0 Classical phenylketonuria
0.000 0.993 0.007
E71.3 Disorders of fatty-acid metabolism
0.000 0.993 0.007
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.993 0.007
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.993 0.007
E71.0 Maple-syrup-urine disease
0.000 0.993 0.007
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.993 0.007
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.993 0.007
E72.5 Disorders of glycine metabolism
0.000 0.993 0.007
E72.4 Disorders of ornithine metabolism
0.000 0.993 0.007
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.993 0.007
E72.2 Disorders of urea cycle metabolism
0.000 0.993 0.007
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.993 0.007
E72.0 Disorders of amino-acid transport
0.000 0.993 0.007
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.993 0.007
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.993 0.007
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.993 0.007
E76.2 Other mucopolysaccharidoses
0.000 0.993 0.007
E76.1 Mucopolysaccharidosis, type II
0.000 0.993 0.007
E76.0 Mucopolysaccharidosis, type I
0.000 0.993 0.007
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.993 0.007
E77.8 Other disorders of glycoprotein metabolism
0.000 0.993 0.007
E77.1 Defects in glycoprotein degradation
0.000 0.993 0.007
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.993 0.007
O80 Single spontaneous delivery
0.007 0.993 0.000
M09 Juvenile arthritis in diseases classified elsewhere
0.000 0.993 0.007
M08 Juvenile arthritis
0.000 0.993 0.007
O80.8 Other single spontaneous delivery
0.007 0.993 0.000
E75.6 Lipid storage disorder, unspecified
0.000 0.993 0.007
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.993 0.007
E75.3 Sphingolipidosis, unspecified
0.000 0.993 0.007
E75.2 Other sphingolipidosis
0.000 0.993 0.007
E75.1 Other gangliosidosis
0.000 0.993 0.007
E75.0 GM2 gangliosidosis
0.000 0.993 0.007
E75.5 Other lipid storage disorders
0.000 0.993 0.007
E84.8 Cystic fibrosis with other manifestations
0.000 0.993 0.007
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.993 0.007
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.993 0.007
M14 Arthropathies in other diseases classified elsewhere
0.000 0.993 0.007

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2026 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.